C

CervoMed
D

CRVO

3.31000
USD
-0.04
(-1.19%)
مفتوح الان
حجم التداول
3,779
الربح لكل سهم
-3
العائد الربحي
-
P/E
-1
حجم السوق
30,646,360
أصول ذات صلة المقالات
المزيد

العنوان: CervoMed

القطاع: Healthcare
الصناعة: Biotechnology
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.